The percentage of patients aged 2 through 64 with a high risk condition, or aged 65 years and older who either received a pneumococcal vaccine (reported separately) or had a contraindication to pneumococcal vaccine (reported separately).
Measure Specs
General Information
Numerator
Two separate numerators:
1. Patients who received a pneumococcal vaccine
2. Patients who have a contraindication to pneumococcal vaccine
Denominator
Patients aged 2 through 64 years with a high risk condition (e.g., diabetes, heart failure, COPD, end-stage kidney disease, nephrotic syndrome, chronic kidney disease, chronic dialysis, asplenia, malignancy, solid organ transplant, on immunosuppressive medications, HIV) or patients aged 65 years and older.
Exclusions
(Words written in all capitals are element names. Please refer to the code set for full description)
Specific Exclusions:
1. Exclusions associated with Validation Rules (see below)
a. Diabetes adult validation is confirmed (see below)
b. Pediatric type 1 diabetes validation is confirmed (see below)
c. Pediatric type 2 diabetes validation is confirmed (see below)
d. Dialysis Chronic Validation is confirmed (see below)
e. CHF Any Stage validation is confirmed (see below)
f. COPD validation is confirmed (see below)
2. Allergy or anaphylactic reaction to the pneumococcal vaccine
General exclusions:
1. Patients who are terminally ill or in Hospice
Measure Record
Point of Contact
This information, including any attachments hereto, is the sole, exclusive, proprietary and confidential property of Active Health Management, Inc., and is for the exclusive use of The National Quality Forum. Any use, copying, disclosure, dissemination or distribution by anyone other than the National Quality Forum is strictly prohibited.
Public Comments